Physician Wealth Advisors’s TG Therapeutics TGTX Stock Holding History

Physician Wealth Advisors’s Portfolio TGTX Stock Details TGTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.48K	Sell	27 -5	-16%	-$205	﹤0.01%	1641
2026 Q1	$1.06K	Buy	+32	New	+$954	﹤0.01%	1646
2025 Q3	–	Sell	-28	Closed	-$1.01K	–	2048
2025 Q2	$1.01K	Buy	28 +5	+22%	+$186	﹤0.01%	1423
2025 Q1	$907	Buy	+23	New	+$774	﹤0.01%	1155

Other funds holding TGTX

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

SOADOR

State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

LSERS

Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

YCM

Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return

TAM

Tealwood Asset Management Minneapolis, Minnesota $261M AUM 52.68% 1-Year Est. Return

COPPSERS

Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

ETC

Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Physician Wealth Advisors's TGTX Position: Q2 2026 in Review

Physician Wealth Advisors reduced its TG Therapeutics (TGTX) stake by 16% in Q2 2026, selling an estimated $205 and leaving 27 shares worth $1.48K. The position accounts for ﹤0.01% of the portfolio, ranked #1641.

Physician Wealth Advisors first reported a position in TGTX in Q1 2025 and has held it in 4 quarters since. 65 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

Physician Wealth Advisors held 27 shares of TG Therapeutics worth $1.48K as of Q2 2026.
Physician Wealth Advisors sold 5 TG Therapeutics shares in Q2 2026, an estimated $205.
TG Therapeutics made up ﹤0.01% of Physician Wealth Advisors's portfolio in Q2 2026, its #1641 holding.
Physician Wealth Advisors first reported a position in TG Therapeutics in Q1 2025 and has held it in 4 quarters since.
65 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on Physician Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.